Literature DB >> 12757040

Increasing prevalence of asthma in UK primary care during the 1990s.

J B Soriano1, V A Kiri, W C Maier, D Strachan.   

Abstract

OBJECTIVE: To estimate recent prevalence trends of physician-diagnosed asthma in primary care in the UK, and to test the hypothesis that the asthma epidemic in the UK peaked in the mid-1990s and is currently declining.
METHODS: A retrospective cohort of asthma patients was obtained from the General Practice Research Database (GPRD). From January 1990 to February 1999, asthmatics were followed up to death, censoring or mention of chronic obstructive pulmonary disease (COPD) in their clinical record. Prevalence rates of ever and managed asthma were obtained by sex, age and calendar year. RESULTS AND
CONCLUSION: From 1990 to 1998, annual prevalence rates of managed physician-diagnosed asthma in women rose from 3.01% (95%CI 2.99-3.03) to 5.14% (95%CI 5.10-5.18), and in men from 3.44% (95%CI 3.41-3.46) to 5.06% (95 %CI 5.02-5.10) (P for trend <0.01 in both). In 1998, prevalence rates of managed asthma in children aged 5-14 affected 7.86% (95%CI 7.71-8.00) of girls and 10.30% (95%CI 10.15-10.47) of boys. Increasing prevalence rates in adult asthma (maximum 4.11% in 1998, 95%CI 4.03-4.19) and elderly asthma (maximum 3.37% in 1998, 95%CI 3.29-3.46) were observed as well in 1998. The study shows that the burden of asthma in UK primary care during the 1990s was still increasing.

Entities:  

Mesh:

Year:  2003        PMID: 12757040

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  18 in total

Review 1.  50 years of asthma: UK trends from 1955 to 2004.

Authors:  H Ross Anderson; Ramyani Gupta; David P Strachan; Elizabeth S Limb
Journal:  Thorax       Date:  2007-01       Impact factor: 9.139

2.  Hearing half the message? A re-audit of the care of patients with acute asthma by emergency ambulance crews in London.

Authors:  H Snooks; M Halter; Y Palmer; H Booth; F Moore
Journal:  Qual Saf Health Care       Date:  2005-12

3.  Measuring disease prevalence: a comparison of musculoskeletal disease using four general practice consultation databases.

Authors:  Kelvin Jordan; Alexandra M Clarke; Deborah P M Symmons; Douglas Fleming; Mark Porcheret; Umesh T Kadam; Peter Croft
Journal:  Br J Gen Pract       Date:  2007-01       Impact factor: 5.386

4.  Impact of asthma on self-reported health status and quality of life: a population based study of Australians aged 18-64.

Authors:  R D Ampon; M Williamson; P K Correll; G B Marks
Journal:  Thorax       Date:  2005-09       Impact factor: 9.139

5.  Trends in the epidemiology of asthma in England: a national study of 333,294 patients.

Authors:  Colin R Simpson; Aziz Sheikh
Journal:  J R Soc Med       Date:  2010-03       Impact factor: 5.344

Review 6.  A review of the use of olopatadine in allergic conjunctivitis.

Authors:  James I McGill
Journal:  Int Ophthalmol       Date:  2004-05       Impact factor: 2.031

7.  Temporal change in the prevalence of respiratory symptoms and obstructive airways disease 1993-2001.

Authors:  Peter I Frank; Paul D Wicks; Michelle L Hazell; Mary F Linehan; Sybil Hirsch; Philip C Hannaford; Timothy L Frank
Journal:  Br J Gen Pract       Date:  2005-08       Impact factor: 5.386

8.  Characteristics of allergic sensitization among asthmatic adults older than 55 years: results from the National Health and Nutrition Examination Survey, 2005-2006.

Authors:  Paula J Busse; Richard D Cohn; Paivi M Salo; Darryl C Zeldin
Journal:  Ann Allergy Asthma Immunol       Date:  2013-02-13       Impact factor: 6.347

9.  Absence of respiratory effects with ivabradine in patients with asthma.

Authors:  K Suresh Babu; Frantisek Gadzik; Stephen T Holgate
Journal:  Br J Clin Pharmacol       Date:  2008-03-13       Impact factor: 4.335

Review 10.  Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.

Authors:  Preeti Gupta; M Sinead O'Mahony
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.